Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy - D'Aimco AV, Moul JW, Carroll PR, Sun L, Lubeck D, Chen M-H, Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, MA. J Natl Cancer Inst 2003;95:1376-1383

Author: Chatta G.  

Publisher: Elsevier

ISSN: 1078-1439

Source: Urologic Oncology: Seminars and Original Investigations, Vol.21, Iss.6, 2003-11, pp. : 487-488

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content